Arcus Biosciences, Inc. (RCUS)
23.92
+0.18
(+0.74%)
USD |
NYSE |
May 21, 16:00
23.92
0.00 (0.00%)
After-Hours: 19:59
Arcus Biosciences Profit Margin (Quarterly) : -752.9% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 28.94% |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Amgen, Inc. | 21.02% |
| Catalyst Pharmaceuticals, Inc. | 42.66% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -69.08% |
| Return on Assets | -32.00% |
| Return on Invested Capital | -56.56% |
| Gross Profit Margin (Quarterly) | 88.24% |
| Operating Margin (Quarterly) | -788.2% |
| Return on Net Operating Assets | -571.2% |